{
    "code": "02024528",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024528",
    "time": "2021-07-16 05:06:59",
    "許可證字號": "衛署藥輸字第024528號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/09\/14",
    "發證日期": "95\/09\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202452802",
    "中文品名": "達菲林長效注射劑11.25毫克",
    "英文品名": "Diphereline  P.R. 11.25 mg, Powder and Solvent for Suspension for Injection (I.M. or S.C.), 3-month prolonged release form",
    "適應症": "1. 攝護腺癌以及子宮內膜異位症之輔助治療。\r\n2. 與放射療法併用且於放射療法結束後繼續投予，用於治療高風險局部性或局部晚期攝護腺癌患者。 \r\n3. 治療中樞性性早熟 (意指女童 8 歲以前及男童 10 歲以前)。",
    "劑型": "243凍晶注射劑",
    "包裝": "1小瓶 附等支數2毫升安瓿 及1注射針筒 2支注射針，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TRIPTORELIN PAMOATE",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "6201099761  法商益普生股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路89號13樓(D室)",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0144000  IPSEN PHARMA BIOTECH",
            "製造廠廠址": "PARC D&#39;ACTIVITES DU PLATEAU DE SIGNES-CHEMIN D&#39;EPARTEMENTAL N&#39;402-83870 SIGNES-FRANCE",
            "製造廠公司地址": "24, RUE ERLANGER-75016 PARIS, FRANCE",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FFR0203100  CENEXI",
            "製造廠廠址": "52, RUE MARCEL ET JACQUES GAUCHER 94120 FONTENAY-SOUS-BOIS FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "溶劑製備"
        },
        {
            "製造廠名稱": "FFR0210000  IPSEN PHARMA BIOTECH",
            "製造廠廠址": "ETABLISSEMENT GAMMASTER, MIN 712 ARNAVAUX, 13323 MARSEILLE CEDEX 14, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "放射線滅菌廠"
        },
        {
            "製造廠名稱": "FFR0271000  IPSEN PHARMA",
            "製造廠廠址": "65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6818000530",
            "成分名稱": "TRIPTORELIN PAMOATE",
            "含量描述": "",
            "含量": "14.5800000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "外觀_Diphereline 11.25mg-製劑-108-07-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024528&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Leaflet_CH_Diphereline PR1125_Approval_TFDA 20190828_Clean_1029-108-10-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024528&Seq=016&Type=9"
        },
        {
            "title": "Diphereline_外盒標籤-108-10-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024528&Seq=012&Type=8"
        }
    ]
}